Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title:Editorial (Hot Topic: Mitochondrion: An Organelle More and More Implication in New Processes)
Volume: 7 Issue: 2
Author(s): Ana Coto-Montes
Affiliation:
Export Options
About this article
Cite this article as:
Coto-Montes Ana, Editorial (Hot Topic: Mitochondrion: An Organelle More and More Implication in New Processes), Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2013; 7 (2) . https://dx.doi.org/10.2174/1872214811307020001
DOI https://dx.doi.org/10.2174/1872214811307020001 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
16
Related Articles
-
Therapeutic Potential of Poncirin Against Numerous Human Health Complications: Medicinal Uses and Therapeutic Benefit of an Active Principle
of Citrus Species
Endocrine, Metabolic & Immune Disorders - Drug Targets Diagnosis of Alterations of Serum Calcium Metabolism
Medicinal Chemistry Phase II and Pharmacological Study of Oral Docetaxel Plus Cyclosporin A in Anthracycline Pre-Treated Metastatic Breast Cancer
Current Clinical Pharmacology The Effects of Dehydroepiandrosterone (DHEA) in the Treatment of Depression and Depressive Symptoms in Other Psychiatric and Medical Illnesses: A Systematic Review
Current Drug Targets Curcumin, an Active Constiuent of the Ancient Medicinal Herb Curcuma longa L.: Some Uses and the Establishment and Biological Basis of Medical Efficacy
CNS & Neurological Disorders - Drug Targets Protein-Tyrosine Phosphatase 1B (PTP1B): A Novel Therapeutic Target for Type 2 Diabetes Mellitus, Obesity and Related States of Insulin Resistance
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Somatostatin Receptor-Targeted Anti-Cancer Therapy
Current Drug Delivery Natural Products on Nonalcoholic Fatty Liver Disease
Current Drug Targets Prediction of the Estrogen Receptor Binding Affinity for both hER<sub>α</sub> and hER<sub>β</sub> by QSAR Approaches
Letters in Drug Design & Discovery Protein-Tyrosine Phosphatase 1B as a Potential Drug Target for Obesity
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Curcumin as an Adjuvant to Breast Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Failure of Immune Homeostasis - The Consequences of Under and Over Reactivity
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Targeting the Type I Insulin-Like Growth Factor System for Breast Cancer Therapy
Current Drug Targets Targeting Six Hallmarks of Cancer in Ovarian Cancer Therapy
Current Cancer Drug Targets Network Medicine and High Throughput Screening
Current Drug Discovery Technologies Relevance of the Chronobiological and Non-chronobiological Actions of Melatonin for Enhancing Therapeutic Efficacy in Neurodegenerative Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Role of Environmental Contaminants in the Etiology of Alzheimer’s Disease: A Review
Current Alzheimer Research Proinflammatory Cytokines and Sickness Behavior in Rheumatic Diseases
Current Pharmaceutical Design Nampt/Visfatin/PBEF: A Functionally Multi-faceted Protein with a Pivotal Role in Malignant Tumors
Current Pharmaceutical Design Immunomodulatory Properties of Thalidomide Analogs: Pomalidomide and Lenalidomide, Experimental and Therapeutic Applications
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)